The BioCode 2500 Multiplex Detection System is a digital optics imaging system f
The BioCode 2500 Multiplex Detection System is a digital optics imaging system for use with Applied BioCode’s Barcoded Magnetic Beads (BMB) technology.
JJQ
Colorimeter, Photometer, Spectrophotometer For Clinical Use
The BioCode MDx 3000 is an automated molecular diagnostic system for use with Ap
The BioCode MDx 3000 is an automated molecular diagnostic system for use with Applied BioCode’s Barcoded Magnetic Beads (BMB) assays.
OOI,PCH
Real Time Nucleic Acid Amplification System,Gastrointestinal Pathogen Panel Mult
Real Time Nucleic Acid Amplification System,Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System
In-vitro multiplex assay used with the Biocode MDx 3000 for the detection of res
In-vitro multiplex assay used with the Biocode MDx 3000 for the detection of respiratory pathogens.
NSU,OZZ,OZY,OZX,OTG,OOU,OEM,OEP,OZE,OCC
Instrumentation For Clinical Multiplex Test Systems,Bordetella Pertussis Dna Ass
Instrumentation For Clinical Multiplex Test Systems,Bordetella Pertussis Dna Assay System,Chlamydophila Pneumoniae Dna Assay System,Mycoplasma Pneumoniae Dna Assay System,Non-Sars Coronavirus Multiplex Nucleic Acid Assay,Parainfluenza Multiplex Nucleic Acid Assay,Human Metapneumovirus (Hmpv) Rna Assay System,Influenza A Virus Subtype Differentiation Nucleic Acid Assay,Influenza A And Influenza B Multiplex Nucleic Acid Assay,Respiratory Virus Panel Nucleic Acid Assay System
2
BioCode Respiratory Pathogen Panel
Other products with the same Product Codes"OOI, PCH"
The Revogene® Strep A assay, performed on the Revogene® instrument, is an automa
The Revogene® Strep A assay, performed on the Revogene® instrument, is an automated, qualitative in vitro diagnostic test that utilizes real-time polymerase chain reaction (PCR) for the direct detection of Streptococcus pyogenes (Group A B-hemolytic Streptococcus) nucleic acids from throat swab specimens obtained from patients with signs and symptoms of pharyngitis. The Revogene Strep A assay is intended for use as an aid in the diagnosis of Group A Streptococcus infection.
The Revogene® Carba C assay, performed on the Revogene® instrument, is a qualita
The Revogene® Carba C assay, performed on the Revogene® instrument, is a qualitative in vitro diagnostic test designed for the detection and differentiation of the blaKPC, blaNDM, blaVIM, blaOXA-48-like, and blaIMP gene sequences associated with carbapenem-non-susceptible pure colonies of Enterobacteriaceae, Acinetobacter baumannii, or Pseudomonas aeruginosa, when grown on blood agar or MacConkey agar. The test utilizes automated real-time Polymerase Chain Reaction (PCR).The Revogene Carba C assay should be used in conjunction with other laboratory tests including phenotypic antimicrobial susceptibility testing. A negative Revogene Carba C assay result does not preclude the presence of other resistance mechanisms.The Revogene Carba C assay is intended as an aid for infection control in the detection of carbapenem-non-susceptible bacteria that colonize patients in healthcare settings. The identification of a blaIMP, blaNDM or blaVIM metallo-B-lactamase gene (i.e., the genes that encode the IMP, NDM and VIM metallo-B-lactamases, respectively) may be used as an aid to clinicians in determining appropriate therapeutic strategies for patients with known or suspected carbapenem non-susceptible infections.
The MOCK PIE is a re-usable PIE intended for use in conjunction with the Revogen
The MOCK PIE is a re-usable PIE intended for use in conjunction with the Revogene® instrument and Revogene® assays. The MOCK PIE simulates the presence of an assay PIE for thermal and rotational balance when the number of assay PIEs is lower than eight in a run.
The Revogene® GBS LB assay performed on the Revogene instrument is a qualitative
The Revogene® GBS LB assay performed on the Revogene instrument is a qualitative in vitro diagnostic test designed to detect Group B Streptococcus (GBS) DNA from 18-24 hour LIM broth enrichments of vaginal/rectal specimen swabs obtained from pregnant women. The Revogene GBS LB assay utilizes automated sample processing and real-time polymerase chain reaction (PCR) to detect a cfb gene sequence specific to the Streptococcus agalactiae genome.The Revogene GBS LB assay is indicated for the identification of antepartum GBS colonization and does not provide susceptibility results. It is not intended to diagnose or monitor treatment of GBS infection. Culture isolates are needed for performing susceptibility testing as recommended for penicillin-allergic women.
The Revogene® instrument is intended for in vitro diagnostic (IVD) use in perfor
The Revogene® instrument is intended for in vitro diagnostic (IVD) use in performing nucleic acid testing of specific IVD assays in clinical laboratories. The Revogene is capable of automated lysis and dilution of samples originating from various clinical specimen types. The Revogene performs automated amplification and detection of target nucleic acid sequences by fluorescence-based real time PCR.
The GenePOC Strep A assay, performed on the revogene instrument, is an automated
The GenePOC Strep A assay, performed on the revogene instrument, is an automated, qualitative in vitro diagnostic test that utilizes real-time polymerase chain reaction (PCR) for the direct detection of Streptococcus pyogenes (Group A B-hemolytic Streptococcus) nucleic acids from throat swab specimens obtained from patients with signs and symptoms of pharyngitis. The GenePOC Strep A assay is intended for use as an aid in the diagnosis of Group A Streptococcus infection.
The GenePOC™ Carba assay, performed on the revogene™ instrument, is a qualitativ
The GenePOC™ Carba assay, performed on the revogene™ instrument, is a qualitative in vitro diagnostic test designed for the detection and differentiation of the blaKPC, blaNDM, blaVIM, blaOXA-48-like, and blaIMP gene sequences associated with carbapenem-non-susceptible pure colonies of Enterobacteriaceae, Acinetobacter baumannii, or Pseudomonas aeruginosa, when grown on blood agar or MacConkey agar. The test utilizes automated real-time Polymerase Chain Reaction (PCR).The GenePOC Carba assay should be used in conjunction with other laboratory tests including phenotypic antimicrobial susceptibility testing. A negative GenePOC Carba assay result does not preclude the presence of other resistance mechanisms.The GenePOC Carba assay is intended as an aid for infection control in the detection of carbapenem-non-susceptible bacteria that colonize patients in healthcare settings. The identification of a blaIMP, blaNDM or blaVIM metallo-B-lactamase gene (i.e., the genes that encode the IMP, NDM and VIM metallo-B-lactamases, respectively) may be used as an aid to clinicians in determining appropriate therapeutic strategies for patients with known or suspected carbapenem non-susceptible infections.
The MOCK PIE is a re-usable PIE intended for use in conjunction with the revogen
The MOCK PIE is a re-usable PIE intended for use in conjunction with the revogene™ instrument and GenePOC assays. The MOCK PIE simulates the presence of an assay PIE for thermal and rotational balance when the number of assay PIEs is lower then eight in a run.
The revogene™ instrument is intended for in vitro diagnostic (IVD) use in perfor
The revogene™ instrument is intended for in vitro diagnostic (IVD) use in performing nucleic acid testing of specific IVD assays in clinical laboratories. The revogene is capable of automated lysis and dilution of samples originating from various clinical specimen types. revogene performs automated amplification and detection of target nucleic acid sequences by fluorescence-based real-time PCR.